<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7391015\results\search\testTrace\results.xml">
  <result pre="City, Hubei Province, China, where the first cases of SARS-CoV-2" exact="infection" post="occurred in early December 2019, toward western countries, resulting"/>
  <result pre="non-urgent care cancelled, how to make priority decisions on patientsâ€™" exact="treatment" post="escalation and how clinicians should act when adequate personal"/>
  <result pre="of the Italian epidemic storm [12]. Polymerase chain reaction (PCR)" exact="testing" post="on respiratory samples, i.e., nasopharyngeal swab, sputum or bronchoalveolar"/>
  <result pre="or bronchoalveolar lavage, is the gold standard for a confirmed" exact="diagnosis" post="of SARS-CoV-2 infection. However, physicians soon learned that in"/>
  <result pre="negative PCR on seven consecutive sputum sample, before achieving the" exact="diagnosis" post="of SARS-CoV-2 infection on the eighth sample [13]. Typical"/>
  <result pre="seven consecutive sputum sample, before achieving the diagnosis of SARS-CoV-2" exact="infection" post="on the eighth sample [13]. Typical and atypical clinical"/>
  <result pre="a protective effect against COVID-19, based on an unexpected low" exact="prevalence" post="of current smokers among Chinese patients hospitalized with COVID-19"/>
  <result pre="countries, allowing to speculate on pharmaceutical nicotine as a potential" exact="treatment" post="option in COVID-19 [24]. To date, there is no"/>
  <result pre="option in COVID-19 [24]. To date, there is no established" exact="treatment" post="for COVID-19. In recent days, remdesivir was the first"/>
  <result pre="Drug Administration (FDA) and European Medicine Agency (EMA) for the" exact="treatment" post="of hospitalized adults with evidence of SARS-CoV-2 lower respiratory"/>
  <result pre="of hydroxychloroquine and azithromycin, which had great resonance and influenced" exact="treatment" post="strategies worldwide, despite important limitations [27, 28]. Depfenhart et"/>
  <result pre="drugs. Immune-modulant drugs and anti-thrombotic prophylaxis are pillars of the" exact="treatment" post="of severe forms. Both arterial and venous thrombotic events"/>
  <result pre="the infusion of hyperimmune plasma from donors recovered from SARS-CoV-2" exact="infection" post="emerged as an attractive option. Perotti et al. presented"/>
  <result pre="and angiotensin II receptor blockers (ARBs), extensively used for the" exact="treatment" post="of hypertension and other cardiovascular diseases, on the natural"/>
  <result pre="on oral anticoagulant drugs, and the high risk of over/under" exact="treatment" post="due to the multiple pharmacological interactions, and the possible"/>
  <result pre="aimed at improving the outpatient management of people on anticoagulant" exact="treatment" post="during COVID-19 pandemic, with particular regard to the lockdown"/>
  <result pre="of COVID-19 pandemic: from the need to rule out coronavirus" exact="infection" post="to emergency percutaneous coronary angioplastyIntern Emerg Med202010.1007/s11739-020-02362-832405816 10.PerliniSCanevariFCortesiSet al.Emergency"/>
  <result pre="a hypothesis worth exploringIntern Emerg Med202010.1007/s11739-020-02389-x32592113 23.FarsalinosKBarbouniANiauraRSystematic review of the" exact="prevalence" post="of current smoking among hospitalized COVID-19 patients in China:"/>
  <result pre="a therapeutic option?Intern Emerg Med202010.1007/s11739-020-02355-732385628 24.PolosaRCaciGCOVID-19: counter-intuitive data on smoking" exact="prevalence" post="and therapeutic implications for nicotineIntern Emerg Med202010.1007/s11739-020-02361-932617903 25.BeigelJHTomashekKMDoddLEet al.Remdesivir"/>
  <result pre="therapeutic implications for nicotineIntern Emerg Med202010.1007/s11739-020-02361-932617903 25.BeigelJHTomashekKMDoddLEet al.Remdesivir for the" exact="treatment" post="of Covid-19â€&quot;preliminary reportN Engl J Med202010.1056/NEJMoa200776432663912 26.GalluccioFErgonencTGarcia MartosAet al.Treatment"/>
  <result pre="point of viewClin Rheumatol20203972077208410.1007/s10067-020-05179-032472459 27.FaninACalegariJBeverinaAet al.Hydroxychloroquine and azithromycin as a" exact="treatment" post="of COVID-19Intern Emerg Med202010.1007/s11739-020-02388-y32474851 28.GautretPLagierJCParolaPet al.Clinical and microbiological effect"/>
  <result pre="pilot observational studyTravel Med Infect Dis20203410166310.1016/j.tmaid.2020.10166332289548 29.DepfenhartMde VilliersDLemperleGet al.Potential new" exact="treatment" post="strategies for COVID-19: is there a role for bromhexine"/>
  <result pre="management of coagulopathy of Covid 19JTH2020181023102632338827 32.Dubois-SilvaÃ�Barbagelata-LÃ³pezCMenaÃ�et al.Pulmonary embolism and" exact="screening" post="for concomitant proximal deep vein thrombosis in noncritically ill"/>
 </snippets>
</snippetsTree>
